|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào):G797305 |
| 產(chǎn)品名稱:GSK 321 |
| 產(chǎn)品CAS:1816331-63-1 |
| 規(guī)格含量:2.5mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
G797305 |
| 名稱: |
GSK 321 |
| 別名: |
(R)-1-(4-Fluorobenzyl)-N-(3-((S)-1-hydroxyethyl)phenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine-3-carboxamide |
| CAS號(hào): |
1816331-63-1 |
| 分子式: |
C??H??FN?O? |
| 分子量: |
501.55 |
| 種類: |
Standards; Enzyme Activators and Inhibitors; |
| 應(yīng)用: |
GSK 321 is a potent and selective IDH1 (isocitrate dehydrogenase 1) mutant inhibitor for the treatment of acute myeloid leukemia. |
| 參考文獻(xiàn) |
|
|
|
|